BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4257896)

  • 21. [Animal experimental studies on the immunosuppressive effect of cytostatic agents].
    Scherf HR; Karsten C; Krüger C
    Langenbecks Arch Chir; 1969; 325():1028-33. PubMed ID: 4984531
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of the dog spleen for studying effects of irradiation and chemotherapeutic agents, with suggested uses of other organs.
    Wilcox LD; De Rose G; Cooke D
    Cancer; 1976 Jul; 38(1):62-72. PubMed ID: 820424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholinesterase genotype and hydrolysis of choline esters, procaine and tetracaine.
    Becker CE
    Hum Hered; 1973 Apr; 23(4):394-9. PubMed ID: 4775465
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of antitumor effect of cyclophosphamide by centrophenoxine.
    Kanzawa F; Hoshi A; Kuretani K
    Gan; 1971 Jun; 62(3):235-6. PubMed ID: 4398065
    [No Abstract]   [Full Text] [Related]  

  • 25. INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
    DOWD JE; DIPAOLO JA; WATNE AL
    Acta Unio Int Contra Cancrum; 1964; 20():279-83. PubMed ID: 14155995
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of antiblastic agents applied either in vivo or in vitro on human lymphocyte transformation in cell culture.
    Astaldi G; Eridani S; Ponti GB; Valentini R; Giangrande A
    Blut; 1969 Apr; 19(1):8-16. PubMed ID: 5789800
    [No Abstract]   [Full Text] [Related]  

  • 27. CANCER CHEMOTHERAPY.
    EISMAN SG; RICHARDSON FM
    Med Sci; 1964 Mar; 15():63-72. PubMed ID: 14143132
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydrolysis of suxamethonium by different types of plasma.
    Hobbiger F; Peck AW
    Br J Pharmacol; 1969 Sep; 37(1):258-71. PubMed ID: 4981001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of anticancer agents on rat prostate. Evaluation of organ weight, histological finding and 5 alpha-reductase activities].
    Takeda M; Hosaka M; Kitajima N; Noguchi K; Fujii H; Oshima H; Harada M
    Hinyokika Kiyo; 1985 Jan; 31(1):71-80. PubMed ID: 2581430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOME PROBLEMS IN THE CHEMOTHERAPY OF SOLID TUMOURS.
    ARONOVITCH M; GROSZMAN M; KAHANA LM
    Can Med Assoc J; 1964 Mar; 90(11):678-84. PubMed ID: 14127380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Qualitative and quantitative measurement of the activity of pseudocholinesterases].
    Longpre J
    Can J Med Technol; 1971 Dec; 33(6):213-27. PubMed ID: 5157097
    [No Abstract]   [Full Text] [Related]  

  • 33. DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
    GOLDENBERG DM
    Dis Chest; 1963 Dec; 51():191-208. PubMed ID: 14102116
    [No Abstract]   [Full Text] [Related]  

  • 34. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
    Valeriote FA; Tolen SJ
    Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
    [No Abstract]   [Full Text] [Related]  

  • 35. [The mechanism of inhibition of serum cholinesterase by various drugs. 1].
    Sato N
    Iryo; 1969 May; 23(5):641-5. PubMed ID: 5805714
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the specificity of anti-proliferative drugs. Comparison of nitrogen mustard, triethylene melamine and cyclophosphamide].
    SCALTRINI GC; TOGNELLA S; CONIGLIARO S; GRIFONI V
    Haematol Lat; 1961; 4():411-22. PubMed ID: 14497771
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of various cytostatic and antiphlogistic agents on the cellular inflammation reaction].
    Trepel F; Schick P; Begemann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 90(4):368-85. PubMed ID: 4179822
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of carcinostatic agents on antitumor activity of sensitized lymphoid cells.
    Hashimoto Y; Sudo H; Ishidate M
    Gan; 1967 Feb; 58(1):31-44. PubMed ID: 4963865
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of the effects of anti-tumour and immunosuppressive drugs on antibody-forming and erythropoietic cells.
    Floersheim GL
    Clin Exp Immunol; 1970 Jun; 6(6):861-70. PubMed ID: 5529340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytostatic effects on nucleic acid- and protein synthesis of benign and malignant lymphomas].
    Trepel F; Stockhusen G; Rastetter J; Begemann H
    Chemotherapy; 1967; 12(3):182-99. PubMed ID: 4168044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.